Ernest Asante‐Appiah
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, HIV Research and Treatment, Hepatitis B Virus Studies, Protein Tyrosine Phosphatases
Most-Cited Works
- → Protein tyrosine phosphatases: the quest for negative regulators of insulin action(2003)189 cited
- → HIV-1 Integrase: Structural Organization, Conformational Changes, and Catalysis(1999)189 cited
- → Molecular mechanisms in retrovirus DNA integration(1997)148 cited
- → In VitroCharacterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor(2013)141 cited
- → Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers(2012)136 cited
- → Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors(2014)107 cited
- → The Structural Basis for the Selectivity of Benzotriazole Inhibitors of PTP1B(2003)104 cited
- → Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses(2013)99 cited
- → A Metal-induced Conformational Change and Activation of HIV-1 Integrase(1997)81 cited
- → Protein Tyrosine Phosphatase-1B Dephosphorylation of the Insulin Receptor Occurs in a Perinuclear Endosome Compartment in Human Embryonic Kidney 293 Cells(2004)76 cited